×
About Us
Overview
Our Leadership
Board of Directors
Scientific Advisory Board
Cell Manufacturing Advisory Board
Strategic Partners
Technology
Allogeneic Cell Therapy Platform
Oncolytic Virus Combinations
CD30 CAR-T Cell Therapy
Manufacturing
Pipeline
TT11X Allogeneic CD30 CAR EBVSTs
TT16 HER2 CAR Ts + CAdVEC
TT11 CD30 CAR Ts
TT11 CD30 CAR Ts + Nivolumab
Expanded Access
Scientific Publications
Investors & Media
Press Releases & Events
Interviews
Careers
Contact Us
×
What are you looking for?
Search for:
About Us
Overview
Our Leadership
Board of Directors
Scientific Advisory Board
Cell Manufacturing Advisory Board
Strategic Partners
Technology
Allogeneic Cell Therapy Platform
Oncolytic Virus Combinations
CD30 CAR-T Cell Therapy
Manufacturing
Pipeline
TT11X Allogeneic CD30 CAR EBVSTs
TT16 HER2 CAR Ts + CAdVEC
TT11 CD30 CAR Ts
TT11 CD30 CAR Ts + Nivolumab
Expanded Access
Scientific Publications
Investors & Media
Press Releases & Events
Interviews
Careers
Contact Us
Interview Series: In Pursuit Of Cancer Cure: Conversations With Immunotherapy Advocates – Jeffrey Bluestone, PhD
by
tessathe
on
May 10, 2019
in
news-videos
<< Back to Press Releases & Events
Previous Reading
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
Next Reading
Tessa Therapeutics Establishes New Scientific Advisory Board